Malta vs OECD members: Treatment for hypertension, male
Malta
65.1%
in 2019
OECD members
54.5%
in 2019
Malta rank
6th
OECD members rank
3rd
Treatment for hypertension, male over time
- Malta
- OECD members
How they compare
Malta currently reports 65.1% against 54.5% in OECD members, a difference of 10.6%.
That makes Malta's figure about 1.2 times OECD members's.
Across all 30 years both countries report, Malta has been ahead every year.
Malta ranks 6th and OECD members ranks 3rd of 192 countries.
Malta has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Malta | OECD members | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 36.8% | 31.8% | 5.0% | Malta |
| 2000s | 49.2% | 43.1% | 6.1% | Malta |
| 2010s | 61.3% | 52.2% | 9.2% | Malta |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment for hypertension, male, Malta or OECD members?
- Malta, at 65.1% against 54.5% in OECD members as of 2019.
- What is the difference in treatment for hypertension, male between Malta and OECD members?
- 10.6%, with Malta ahead.
- How many years of comparable data are there for Malta and OECD members?
- 30 years are reported by both, from 1990 to 2019.
- How do Malta and OECD members rank globally for treatment for hypertension, male?
- Malta ranks 6th and OECD members ranks 3rd of 192 countries.
- Where does this data come from?
- World Health Organization's Global Health Observatory Data Repository, published as Treatment for hypertension, male (% of male adults ages 30-79 with hypertension). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Treatment for hypertension, male, is the percentage of adults ages 30-79 with hypertension who were taking medicine for hypertension. Hypertension is defined as having systolic blood pressure =140 mmHg, diastolic blood pressure =90 mmHg, or taking medication for hypertension.